Trials / Active Not Recruiting
Active Not RecruitingNCT05967091
Ryme Medical TLD Pilot Study
Targeted Lung Denervation (TLD) With the Ryme Medical Lung Denervation System in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Ryme Medical TLD Pilot Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ryme Medical, Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Targeted lung denervation (TLD) with the Ryme Medical Lung Denervation System in patients with chronic obstructive pulmonary disease (COPD) - Ryme Medical TLD Pilot Study
Detailed description
The study is a prospective, multi-center, non-randomized study to evaluate the safety and performance of the Ryme Medical Lung Denervation System in patients with chronic obstructive pulmonary disease (COPD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Targeted Lung Denervation | Targeted Lung Denervation (TLD) is a bronchoscopically guided, minimally invasive procedure using the Ryme Medical Lung Denervation System |
Timeline
- Start date
- 2024-03-06
- Primary completion
- 2025-05-22
- Completion
- 2026-05-01
- First posted
- 2023-08-01
- Last updated
- 2025-08-13
Locations
7 sites across 6 countries: Australia, Austria, Denmark, Georgia, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT05967091. Inclusion in this directory is not an endorsement.